Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Research Article
On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation
, , , , , , & 
show all
Chuanlai ShenDepartment of Microbiology and Immunology, Medical School, Southeast University, Nanjing, Jiangsu, China; Correspondence[email protected]
http://orcid.org/0000-0002-3748-3742View further author information
http://orcid.org/0000-0002-3748-3742View further author information show allRelated Research Data
PLGA-based nanoparticles: An overview of biomedical applications
Source:
Elsevier BV
On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation
Source:
Taylor & Francis
Apoptotic cell clearance: basic biology and therapeutic potential
Source:
Springer Nature
Biomimetic delivery with micro- and nanoparticles.
Source:
(:unav)
Micro and Nanoparticle Drug Delivery Systems for Preventing Allotransplant Rejection
Source:
Elsevier BV
Biomaterial Strategies for Immunomodulation
Source:
Annual Reviews
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
Source:
Springer Science and Business Media LLC
Strategies to direct the enrichment, expansion, and recruitment of regulatory cells for the treatment of disease.
Source:
Springer Science and Business Media LLC
On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation
Source:
Taylor & Francis
Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation
Source:
Wiley
A Novel Process for Modifying Pharmacokinetics
Source:
Springer Science and Business Media LLC
Multivalent Nanomaterials: Learning from Vaccines and Progressing to Antigen-Specific Immunotherapies
Source:
Elsevier BV
Biomimetic particles as therapeutics
Source:
Elsevier BV
Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation.
Source:
Elsevier BV
Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels
Source:
Elsevier BV
CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity
Source:
Elsevier BV
CD47 Is Required for Suppression of Allograft Rejection by Donor-Specific Transfusion
Source:
The American Association of Immunologists
Role of particle size in phagocytosis of polymeric microspheres.
Source:
Springer Science and Business Media LLC
Current advances in research and clinical applications of PLGA-based nanotechnology
Source:
Informa UK Limited
Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection
Source:
Elsevier BV
Regulatory dendritic cell therapy: From rodents to clinical application
Source:
Elsevier BV
Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging
Source:
Elsevier BV
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Source:
Proceedings of the National Academy of Sciences
An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T Cells
Source:
Frontiers Media SA
Role of CD47 as a marker of self on red blood cells.
Source:
American Association for the Advancement of Science (AAAS)
Linking provided by
